Skip to main content
High RiskFDAfda-F-1324-2019UNDECLARED ALLERGEN

Stanganellis Italian Foods, Pumpkin Cake Roll, Net Wt. 24 oz. . One pie per package . Box.

Units Affected
80
Recall Date
March 26, 2019
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1324-2019.

Stanganellis Italian Foods, is initiating a recall of Pumpkin Cake Roll, Net Wt. 24 oz. . One per package, because of product miss-labeling. The firm inadvertently left off the allergen statement that soy was used in making the product.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1324-2019.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Spagel Brothers, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1324-2019.

Spagel Brothers, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Spagel Brothers, Inc. Recall FAQ

Spagel Brothers, Inc. is the subject of a bakery & grains safety report: Stanganellis Italian Foods, Pumpkin Cake Roll, Net Wt. 24 oz. . One pie per package . Box.. The notice was published on March 26, 2019 by the U.S. Food and Drug Administration (FDA). Approximately 80 units are potentially affected.